Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
4Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Founder and Managing Partner of GenNx360 Capital Partners, a private equity buyout firm, since 2006. Previously founded, served as Chairman and CEO of Blaylock & Company, Inc., an investment banking firm from 1993 to 2006. Held senior management positions at PaineWebber Group and Citicorp. Currently serves on Board of Pfizer Inc. and is Trustee of Carnegie Hall and NYU Stern School of Business.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Director

Pfizer (NYSE: PFE)

Jan 1, 2017 – Present

Independence: Not stated

Source effective: 2017-01-01 · Observed: 2026-05-03T01:47:45.110153+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Pfizer

2017-01-01 · current

Confirmed by public sourceView source

Director

W. R. Berkley Corporation

2001-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Pfizer

Open Pfizer profile →

Director at Pfizer

2017-01-01 → End not stated

current · source reported

Observed: 2026-09-21

PfizerPfizerW. R. Berkley Corp…W. R. Berkley CorporationRonald E. Blaylock

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingWRB DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 2 · Sec FilingPfizer director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:ronald-e-blaylock
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board independence · CorroboratedIndependent directorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of PfizerSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of W. R. Berkley CorporationSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · CorroboratedBoard role: DirectorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 30, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Compensation1 source
Verification
Source reported
Confidence
88%
Last reviewed
Apr 30, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 30, 2026

Committee assignments · Source reportedCommittee assignments: Business Ethics, Compensation, Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at GenNx360 Capital Partners1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 6, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Founder and Managing Partner1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 6, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources8 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  3. https://www.sec.gov/Archives/edgar/data/11544/000119312526170583/d82252ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 23, 2026

    Supports: Director at W. R. Berkley Corporation (NYSE: WRB-PH)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 30, 2026

    Supports: Board role · Committee assignments

  6. https://www.sec.gov/Archives/edgar/data/78003/000007800326000033/pfe-20260312.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at Pfizer (NYSE: PFE)

  7. https://www.sec.gov/Archives/edgar/data/78003/000007800326000033/pfe-20260312.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  8. https://www.sec.gov/Archives/edgar/data/11544/000119312526170583/d82252ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership